Non-targeted metabolomics identifies erythronate accumulation in cancer cells
J. Zhang, M. A. Keibler, W. Dong, J. Ghelfi, T. Cordes, T. Kanashova, A. Pailot, C. Linster, G. Dittmar, C. M. Metallo, T. Lautenschlaeger, K. Hiller, G. Stephanopoulos
The paper identifies erythronate accumulation in cancer cells using non-targeted metabolomics and suggests it may serve as a cancer biomarker.
bioRxiv · Dec 4, 2022 · PreprintBiochemistry